During the last few years, adenoviral gene transfer techniques have achieved increasing interest in the treatment of neurodegenerative diseases. However, gene therapy requires that delivered genes are translated into proteins. This may pose a problem in focal ischemia where protein synthesis is compromized. The present study was conducted to find out the feasibility of adenoviral GDNF and CNTF delivery in transient focal ischemia, as induced by 30 min of intraluminar middle cerebral artery (MCA) occlusion in mice. Injections of vehicle, of an adenoviral vector deleted in the E1 region (Ad-dE1) and of vectors expressing the GDNF (Ad-GDNF), CNTF (Ad-CNTF), or GFP (Ad-EGFP) gene from a CMV promoter were stereotactically placed in the dorsolateral striatum, i.e., the core of the MCA territory, and focal ischemia was induced seven days later. Thread occlusion resulted in disseminated injury of the striatum, but not the overlying cortex. The number of viable neurons was significantly increased after 1 and 3 days of reperfusion both in Ad-GDNF and Ad-CNTF as compared with vehicle or Ad-dE1-treated animals, whereas the number of injured cells was significantly reduced, as shown by cresyl violet staining, terminal transferase biotinylated-dUTP nick end-labeling (TUNEL), and immunocytochemistry for activated caspase-3. Interestingly, the protective effects of Ad-GDNF were similarly strong in areas of the striatum adjacent and remote of the adenoviral infusion site, while Ad-CNTF showed pronounced rescue effects in the surrounding, but rather little effects distant to the infusion. The present study demonstrates that adenoviral delivery of neurotrophic factors may be a useful tool for the treatment of focal ischemia.
INTRODUCTION
During the last few years, viral gene transfer techniques have achieved increasing interest in the treatment of neurodegenerative diseases (Bilang-Bleuel et al., 1997; Choi-Lundberg et al., 1997; Mandel et al., 1999) and traumatic brain injury (Isenmann et al., 1998; Kü gler et al., 1999) . The approach requires that delivered genes are translated into proteins. This may pose a problem in focal ischemia, where cerebral protein synthesis is compromized (Hata et al., 2000a, b; Hermann et al., 2001) . We recently examined the evolution of injury in mice subjected to a 30 min episode of intraluminal thread occlusion using multiparametric metabolic imaging techniques (Hermann et al., 2001) . We demonstrated that even after such mild ischemic episodes a long-lasting inhibition of protein synthesis is induced in the striatum, where disseminated injury evolves (Hermann et al., 2001 ). The present study was conducted to examine whether adenoviral gene transfer may be used as a treatment strategy in focal brain ischemia. In order to address this issue, we made stereotactic injections of adenoviral vectors in the dorsolateral portion of the striatum, which is the core
